Live Breaking News & Updates on Cellectar Biosciences Daily

Stay updated with breaking news from Cellectar biosciences daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cellectar Biosciences (CLRB) to Release Earnings on Tuesday

Cellectar Biosciences (CLRB) to Release Earnings on Tuesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Roth Mkm , Cellectar Biosciences , Cellectar Biosciences Company Profile , Cellectar Biosciences Inc , Get Free Report , Cellectar Biosciences Daily ,

Cellectar Biosciences (CLRB) Set to Announce Earnings on Tuesday

Cellectar Biosciences (CLRB) Set to Announce Earnings on Tuesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cellectar Biosciences , Roth Mkm , Cellectar Biosciences Inc , Cellectar Biosciences Company Profile , Get Free Report , Cellectar Biosciences Daily ,

Roth Mkm Boosts Cellectar Biosciences (NASDAQ:CLRB) Price Target to $28.00

Cellectar Biosciences (NASDAQ:CLRB – Free Report) had its price target lifted by Roth Mkm from $20.00 to $28.00 in a research note published on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. CLRB has been the subject of a number of other research reports. StockNews.com upgraded Cellectar […] ....

Roth Mkm , Cellectar Biosciences , Renaissance Technologies , Cellectar Biosciences Inc , Citadel Advisors , Acuta Capital Partners , Cellectar Biosciences Company Profile , Free Report , Capital Partners , Bridge Advisors , Street Corp , Get Free Report , Cellectar Biosciences Daily ,

Short Interest in Cellectar Biosciences, Inc. (NASDAQ:CLRB) Grows By 208.6%

Cellectar Biosciences, Inc. (NASDAQ:CLRB – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 1,670,000 shares, a growth of 208.6% from the December 31st total of 541,100 shares. Based on an average daily trading volume, of 1,130,000 […] ....

Cellectar Biosciences , Cellectar Biosciences Company Profile , Wealth Management , Worth Venture Partners , Citadel Advisors , Renaissance Technologies , Cellectar Biosciences Inc , Get Free Report , Street Corp , Venture Partners , Cellectar Biosciences Daily , Nasdaq Clrb ,

Financial Analysis: Cellectar Biosciences (NASDAQ:CLRB) vs. Merrimack Pharmaceuticals (NASDAQ:MACK)

Financial Analysis: Cellectar Biosciences (NASDAQ:CLRB) vs. Merrimack Pharmaceuticals (NASDAQ:MACK)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New Jersey , United States , Florham Park , United Kingdom , Cellectar Bioscience , Cellectar Biosciences , Cellectar Biosciences Inc , Merrimack Pharmaceuticals Inc , Merrimack Pharmaceuticals , Get Free Report , Merrimack Pharmaceutical , Given Cellectar Bioscience , Orano Med , Cellectar Biosciences Daily ,